Advertisement
Australia markets closed
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • AUD/USD

    0.6519
    -0.0017 (-0.25%)
     
  • OIL

    82.74
    +1.39 (+1.71%)
     
  • GOLD

    2,239.10
    +26.40 (+1.19%)
     
  • Bitcoin AUD

    108,411.62
    +2,351.60 (+2.22%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6036
    +0.0005 (+0.08%)
     
  • AUD/NZD

    1.0901
    +0.0021 (+0.19%)
     
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NASDAQ

    18,241.32
    -39.52 (-0.22%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,754.79
    -5.29 (-0.01%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     

Indonesia in talks to buy Merck's COVID-19 antiviral pill - minister

JAKARTA, Oct 25 (Reuters) - Indonesia is "finalising" a deal with Merck & Co to procure its experimental antiviral pills, named molnupiravir, to treat COVID-19 ailments, its health minister said on Monday.

Results https://www.reuters.com/business/healthcare-pharmaceuticals/mercks-covid-19-pill-cuts-risk-death-hospitalization-by-50-study-2021-10-01 from a large clinical trial this month showed that the pill, made with Ridgeback Biotherapeutics, cut hospitalisations and deaths by 50%. Merck asked for an emergency use clearance from the United States earlier this month.

Health Minister Budi Gunadi Sadikin told a news conference that the deal is being finalised so that the first shipment of molnupiravir may come at the end of the year after a visit to the company in the U.S.

"So that we have enough stock to withstand a potential next wave," he said, adding that Indonesia and Merck are in talks to build a production plant in Indonesia to produce raw material.

ADVERTISEMENT

Budi did not say how many pills are being procured. Merck did not immediately respond to a request for comment.

Merck has signed supply deals for the drug with Indonesia's neighbours Malaysia and Singapore, as well as Britain.

Indonesia was Asia's COVID-19 epicentre in July, largely fuelled by the virulent Delta variant, although cases and deaths have largely plummeted recently.

The government said on Monday it is anticipating a potential infection spike brought by the upcoming Christmas holidays. (Reporting by Stanley Widianto; Editing by Christian Schmollinger)